Belbuca 600 MCG film 60S
Ended Awarded
- Contract number
- SPE2DB26FGLYX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,124
Award facts
- Contract value 100% obligated
- $1,123.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Belbuca 600 mcg film (60 count) with a ceiling value of $1,123.96. This firm fixed price delivery order represents a non-competitive, non-set-aside award and is set for ultimate completion by October 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. Belbuca is a brand-name opioid film formulation used for pain management, consistent with the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains. The DLA Medical Supply Chain relies on AmerisourceBergen's capabilities to fulfill diverse federal medical supply requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, making this small-value delivery order part of the company's broader strategic role in supporting Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FGLYX?
SPE2DB26FGLYX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FGLYX worth?
The government has obligated $1,124 on SPE2DB26FGLYX.
Is contract SPE2DB26FGLYX an order under another contract?
Yes. SPE2DB26FGLYX is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB26FGLYX competed?
The extent of competition for SPE2DB26FGLYX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award